Endoscopy 2012; 44(12): 1089-1095
DOI: 10.1055/s-0032-1325734
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett’s esophagus neoplasia

C. Jayasekera
1   Department of Gastroenterology, St Vincent’s Hospital, Melbourne, Australia
,
A. C. F. Taylor
1   Department of Gastroenterology, St Vincent’s Hospital, Melbourne, Australia
,
P. V. Desmond
1   Department of Gastroenterology, St Vincent’s Hospital, Melbourne, Australia
,
F. Macrae
2   Department of Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia
,
R. Williams
1   Department of Gastroenterology, St Vincent’s Hospital, Melbourne, Australia
› Author Affiliations
Further Information

Publication History

submitted 28 January 2012

accepted after revision 22 July 2012

Publication Date:
27 November 2012 (online)

Background and study aims: Advances in endoscopic imaging techniques have enabled more accurate identification of subtle mucosal abnormalities. The aim of the study was to assess the accuracy of predicting high grade dysplasia (HGD) and intramucosal cancer (IMC) in mucosa predicted as being nondysplastic vs. dysplastic by high definition white light endoscopy (HD-WLE), narrow band imaging (NBI), and confocal laser endomicroscopy (CLE).

Patients and methods: A cross-sectional study was performed in a tertiary referral setting between February 2010 and September 2011. A total of 50 consecutive patients who were referred to St Vincent’s Hospital for management of dysplastic Barrett’s esophagus were included. A prediction of likely histology was made for each mucosal point (four-quadrant every 1 cm and any visible mucosal abnormality), first with HD-WLE, followed by NBI, and finally CLE. Biopsies were taken at all of these points.

Results: A total of 1190 individual biopsy points were assessed. At histology, 39 biopsy points were found to harbor HGD and 52 biopsy points harbored IMC. For the detection of HGD/IMC the sensitivity, specificity, and accuracy were: HD – WLE, 79.1 %, 83.1 %, and 82.8 %; NBI, 89.0 %, 80.1 %, and 81.4 %; and CLE, 75.7 %, 80.0 %, and 79.9 %, respectively. All mucosal points with IMC and all patients with HGD were detected by targeted biopsies guided by HD-WLE and NBI without the need for random Seattle protocol biopsies.

Conclusions: HD-WLE in combination with NBI is highly accurate in the detection of HGD/IMC. Performing targeted biopsies in the surveillance of Barrett’s esophagus is possible in expert centers.

 
  • References

  • 1 Sharma P. Clinical practice. Barrett’s esophagus. N Engl J Med 2009; 361: 2548-2556
  • 2 Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 2008; 103: 788-797
  • 3 Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 2002; 287: 1972-1981
  • 4 Reid BJ. Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 1991; 20: 817-834
  • 5 Rastogi A, Puli S, El-Serag HB et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008; 67: 394-398
  • 6 Buttar NS, Wang KK, Sebo TJ et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630-1639
  • 7 Konda VJ, Ross AS, Ferguson MK et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated?. Clin Gastroenterol Hepatol 2008; 6: 159-164
  • 8 Spechler SJ, Sharma P, Souza RF et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140: 1084-1091
  • 9 Cruz-Correa M, Gross CP, Canto MI et al. The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians. Arch Intern Med 2001; 161: 2588-2595
  • 10 Sharma P, Bansal A. Toward better imaging of Barrett’s esophagus – see more, biopsy less!. Gastrointest Endosc 2006; 64: 188-192
  • 11 Kiesslich R, Burg J, Vieth M et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004; 127: 706-713
  • 12 Kiesslich R, Gossner L, Goetz M et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006; 4: 979-987
  • 13 Anagnostopoulos GK, Yao K, Kaye P et al. Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther 2007; 26: 501-507
  • 14 Kara MA, Ennahachi M, Fockens P et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett’s esophagus by using narrow band imaging. Gastrointest Endosc 2006; 64: 155-166
  • 15 Sharma P, Bansal A, Mathur S et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrointest Endosc 2006; 64: 167-175
  • 16 Kerkhof M, van Dekken H, Steyerberg EW et al. Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007; 50: 920-927
  • 17 Curvers WL, Ten Kate FJ, Krishnadath KK et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010; 105: 1523-1530
  • 18 Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001; 32: 368-378
  • 19 Wolfsen HC, Crook JE, Krishna M et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus. Gastroenterology 2008; 135: 24-31
  • 20 Kara MA, Peters FP, Fockens P et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus. Gastrointest Endosc 2006; 64: 176-185
  • 21 Curvers WL, Singh R, Song LM et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008; 57: 167-172
  • 22 Curvers WL, Ten Kate FJ, Krishnadath KK et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett’s esophagus. Gastroenterology 2010; 139: 1106-1114
  • 23 Curvers WL, van Vilsteren FG, Baak LC et al. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett’s neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc 2011; 73: 195-203
  • 24 Sharma P, Meining AR, Coron E et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74: 465-472